Biotech · Private company · Waconia, MN, US
Panbela Therapeutics, Inc.
SEC CIK 0001029125
Track this companyFree. Adds Panbela Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- GemcitabinePhase 3 · Pancreatic Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- Nab-paclitaxelPhase 3 · Pancreatic Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- SBP-101Phase 3 · Pancreatic Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- Gemcitabine InjectionPhase 1 · Pancreatic Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate CancerPHASE2 · RECRUITING · started Oct 4, 2023ClinicalTrials.gov NCT06059118 · fetched Nov 12, 2026
- Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic CancerPHASE2_PHASE3 · RECRUITING · started Aug 8, 2022ClinicalTrials.gov NCT05254171 · fetched Nov 12, 2026
- Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic CancerPHASE1 · COMPLETED · started Jun 4, 2018ClinicalTrials.gov NCT03412799 · fetched Nov 12, 2026
SEC filings6
- 8-K · FORM 8-KSEC EDGAR · filed Feb 18, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Feb 4, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jan 22, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 18, 2024 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed Nov 14, 2024 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 14, 2024 · fetched Nov 12, 2026